Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive
Will either Moody's or S&P downgrade LYB's senior unsecured rating by year-end 2026?
Current Prediction
Why This Question Matters
Tests the downside tail of the funding-fragility storyline. LYB is rated Baa2/BBB; $8.1B liquidity is a defensive cushion but the $(738)M FY2025 GAAP loss and elevated capex produce negative FCF pressure. A downgrade by either Moody's or S&P signals that agencies view the cycle as extending meaningfully longer than management suggests. No downgrade supports the FUNDING_FRAGILITY ADEQUATE classification. This is a structured probe of the 25% extended-cycle probability path.
Prediction Distribution
Individual Predictions(9 runs)
Committee labels FUNDING_FRAGILITY as ADEQUATE; $8.1B liquidity + $1.5B pre-funding + 95% cash conversion are rating-positive. Expected Feb 2026 dividend cut (separate market ~60% prob of 40%+ cut) directly relieves rating pressure. Agencies have shown patience through 2024-2025 trough without action. However: BASF was downgraded 2024 during similar cycle; cycle extension through 2026 could trigger BBB→BBB- action by S&P or Baa2→Baa3 by Moody's. Base rate for BBB cyclical downgrade during extended trough ~25-35%. Settle 0.28 reflecting moderate tail risk.
Rating-positive factors dominate: $8.1B liquidity is strong cushion; pre-funding executed; operational discipline credible (VEP, CIP); committee's ADEQUATE funding assessment. Dividend cut defuses primary pressure mechanism. Agencies typically require sustained multi-year evidence for IG downgrade; LYB's cycle is at trough now so even if cycle extends through 2026, agency decision typically lags into 2027. 0.20-0.28. Settle 0.25.
Two-way risk: (1) If dividend cut is not large enough (< 40% in separate market, ~40% probability), if Saudi JV commitment accelerates (low probability), if European divestiture proceeds fall short — compounding pressure could trigger downgrade. (2) If Q1 EBITDA disappoints, adds negative momentum. Base rate for Baa2/BBB during extended chemical cycle trough is ~30%. Meta placed credit reviews as Q2-Q4 2026 monitoring trigger, implying possibility is real. Settle 0.30.
Committee labels ADEQUATE not STRAINED; cushion is real; dividend lever active. Downgrade probability moderate at 20-30%. 0.25 central.
Model Moody's and S&P independently: P(Moody's downgrade) ~15%, P(S&P downgrade) ~15-20%. Union with ~10% correlation ~25-28%. Settle 0.28.
Conservative: liquidity cushion, dividend discretion, and operational credibility argue against near-term downgrade. Agency lag typical. 0.20-0.25.
Moderate probability 25-30%. Committee ADEQUATE + dividend lever + patience already shown argue against; extended cycle + GAAP loss could still trigger. 0.27.
25% reflects balance between funding-adequate baseline and extended-cycle tail risk.
Base rate 25-30% for BBB/Baa2 during extended trough. Settle 0.28.
Resolution Criteria
Resolves YES if either Moody's Investors Service or S&P Global Ratings publishes a rating action between 2026-04-22 and 2026-12-31 that lowers LYB's senior unsecured (or equivalent long-term issuer) rating by one or more notches. Negative outlook changes without rating movement do NOT count. Includes rating withdrawals only if accompanied by a downgrade action. Resolves NO if neither agency downgrades, or if either agency upgrades LYB during the period.
Resolution Source
Moody's and S&P Global Ratings press releases and rating action announcements
Source Trigger
Credit rating agency reviews post-Q1 2026 — ratings pressure given GAAP losses, negative FCF environment, and dividend sustainability questions
Full multi-lens equity analysis